Edition:
United Kingdom

ACADIA Pharmaceuticals Inc (ACAD.OQ)

ACAD.OQ on NASDAQ Stock Exchange Global Select Market

19.47USD
24 Apr 2018
Change (% chg)

$-0.45 (-2.26%)
Prev Close
$19.92
Open
$20.00
Day's High
$20.02
Day's Low
$19.32
Volume
511,891
Avg. Vol
619,117
52-wk High
$41.20
52-wk Low
$15.74

Chart for

About

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. Its lead drug candidate, NUPLAZID (pimavanserin), is used for the treatment of hallucinations and delusions associated with Parkinson's disease... (more)

Overall

Beta: 3.76
Market Cap(Mil.): $4,717.31
Shares Outstanding(Mil.): 122.40
Dividend: --
Yield (%): --

Financials

  ACAD.OQ Industry Sector
P/E (TTM): -- 84.02 32.74
EPS (TTM): -2.53 -- --
ROI: -74.14 1.58 14.38
ROE: -74.18 2.41 16.07

BRIEF-Acadia Pharma Q4 Loss Per Share $0.55

* ACADIA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

27 Feb 2018

BRIEF-Acadia Pharmaceuticals posts Q3 loss of $0.53 per share

* Acadia Pharmaceuticals reports third quarter 2017 financial results

07 Nov 2017

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $37.06 +0.26
Eli Lilly And Co (LLY.N) $80.09 -0.11
Eisai Co., Ltd (4523.T) ¥7,348 +210.00

Earnings vs. Estimates